Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    GLYX13-C-202
Show Display Options
Rank Status Study
1 Not yet recruiting Open Label Extension for GLYX13-C-202, NCT01684163
Condition: Major Depressive Disorder
Intervention: Drug: GLYX-13
2 Completed Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants
Condition: Major Depressive Disorder
Interventions: Drug: GLYX-13;   Drug: Placebo

Indicates status has not been verified in more than two years